Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > WA Providers

Dr. Brian Gerald Till, MD

(No ratings)

Specializes in: Medical Oncology and Adult Oncology

University of Chicago, Pritzker School of Medicine (2002)

Professional interests include: telehealth services

1354 Aloha Street
Seattle, WA 98109

1-855-557-0555

Dr. Brian Gerald Till, MD is a medical oncologist in Seattle, WA specializing in medical oncology and adult oncology. He graduated from University of Chicago, Pritzker School of Medicine in 2002 and has 22 years of experience. Dr. Brian Gerald Till, MD is affiliated with UW Medicine and ASSOCIATION OF UNIVERSITY PHYSICIANS.

Office Locations

Address:

1354 Aloha Street
Seattle, WA 98109

Address:

1959 Ne Pacific Street C-212, Box 356340
Seattle, WA 98195

In The News

“The updated results from the single-institution Phase 1/2 clinical trial were presented during a poster session at the European Hematology Association 2024 Hybrid Congress ("EHA2024") by Brian...”—"Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy", News10, June 2024

“The CAR T was developed by Mustang's research collaborator, Fred Hutch, in the laboratories of the late Oliver Press, M.D., Ph.D., and Brian Till, M.D., Associate Professor in the Clinical Research...”—"Mustang Bio Announces Updated Interim Results from Follicular Lymphoma Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted CAR T Therapy", Associated Press News, June 2022

“The CAR T was developed by Mustang's research collaborator, Fred Hutch, in the laboratories of the late Oliver Press, M.D., Ph.D., and Brian Till, M.D., Associate Professor in the Clinical Research...”—"Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106, CD20-Targeted CAR T Therapy, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia", Associated Press News, April 2022

doctor visit	25

Hypertension	70
High Cholesterol	65
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

doctor visit	50

**Gender**
Male	23
Female	11

**Age**
From 65 to 74	23
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	59
High Cholesterol	32
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	32
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

doctor visit	36

**Gender**
Male	36
Female	22

**Age**
From 65 to 74	28
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	55
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	41
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

doctor visit	60

Hypertension	62
High Cholesterol	48
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	45
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

doctor visit	62

**Gender**
Male	21
Female	11

Hypertension	53
High Cholesterol	38
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	41
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

doctor visit	48

**Gender**
Male	22
Female	16

**Age**
From 65 to 74	18
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	68
High Cholesterol	34
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	39
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

doctor visit	114

**Gender**
Male	36
Female	16

**Age**
From 65 to 74	33
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	58
High Cholesterol	54
Stroke	0
Ischemic Heart Disease	37
Depression	23
Chronic Kidney Disease	35
Asthma	0
Osteoperosis	0
Atrial Fibrilation	21
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

doctor visit	125

**Gender**
Male	36
Female	18

**Age**
From 65 to 74	36
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	65
High Cholesterol	52
Stroke	0
Ischemic Heart Disease	28
Depression	20
Chronic Kidney Disease	31
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	20
Chronic Obstructive Pulmonary Disease	0
Diabetes	24
Dementia	0
Cancer	0

doctor visit	216

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Brian Gerald Till, MD for Medicare patients.

doctor visit	83

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Brian Gerald Till, MD.

**Gender**
Male	17
Female	9

**Age**
75 to 84	0
85 and over	0
Less than 65	0
65 to 74	13

Average of Total of Conditions of Medicare patients treated by Dr. Brian Gerald Till, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Brian Gerald Till, MD treated were hypertension, high cholesterol, chronic kidney disease and depression.

Hypertension	49
High Cholesterol	32
Stroke	0
Ischemic Heart Disease	6
Depression	8
Chronic Kidney Disease	22
Asthma	0
Osteoporosis	0
Heart Failure	2
Chronic Obstructive Pulmonary Disease	0
Diabetes	2
Atrial Fibrillation	2
Cancer	0
Dementia	0

Education & Training

Dr. Brian Gerald Till, MD graduated from University of Chicago, Pritzker School of Medicine in 2002. He has a state license in Washington.

Medical School: University of Chicago, Pritzker School of Medicine (2002)

Licensed In: Washington

Affiliations & Hospitals

Dr. Brian Gerald Till, MD is associated with these hospitals and organizations:

UW Medicine

ASSOCIATION OF UNIVERSITY PHYSICIANS

Ratings & Reviews

Dr. Brian Gerald Till, MD does not have any reviews yet, be the first to leave a review of Dr. Brian Gerald Till, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Brian Gerald Till, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Pfizer Inc.	$12,818 $12,818
F. Hoffmann-La Roche AG	$2,298 TECENTRIQ $2,298
Eli Lilly and Company	$190 $190
ADC Therapeutics America, Inc.	$143 $143

**Types of Payments**
Grant	$12,818
Consulting Fee	$2,298
Food and Beverage	$333

Research Payments

Dr. Brian Gerald Till, MD has received 10 research payments totaling $201,533.

Biography

Dr. Brian Till practices adult oncology and medical oncology in Seattle, WA. His areas of expertise include telehealth services. Dr. Till is professionally affiliated with UW Medicine. He studied medicine at the University of Chicago, Pritzker School of Medicine. In addition to English, Dr. Till speaks Spanish.